Nimrata Hunt - Aug 6, 2025 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Role
Executive Vice President
Signature
/s/ Lily J. Lu, Attorney-in-Fact for Nimrata Hunt
Stock symbol
IDXX
Transactions as of
Aug 6, 2025
Transactions value $
-$2,103,365
Form type
4
Date filed
8/8/2025, 09:00 PM
Previous filing
Jun 2, 2025
Next filing
Aug 13, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Hunt Nimrata Executive Vice President ONE IDEXX DRIVE, WESTBROOK /s/ Lily J. Lu, Attorney-in-Fact for Nimrata Hunt 2025-08-08 0001800619

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IDXX Common Stock Options Exercise $172K +1.22K +9.86% $141.60 13.6K Aug 6, 2025 Direct F1
transaction IDXX Common Stock Options Exercise $1.05M +5.87K +43.21% $178.26 19.4K Aug 6, 2025 Direct
transaction IDXX Common Stock Options Exercise $1.18M +5.71K +29.38% $206.94 25.1K Aug 6, 2025 Direct
transaction IDXX Common Stock Sale -$1.9M -3.02K -12% $629.87 22.1K Aug 6, 2025 Direct
transaction IDXX Common Stock Sale -$1.83M -2.91K -13.13% $630.91 19.2K Aug 6, 2025 Direct F2
transaction IDXX Common Stock Sale -$768K -1.22K -6.34% $630.69 18K Aug 6, 2025 Direct
holding IDXX Common Stock 160 Aug 6, 2025 jointly with spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDXX Non-Qualified Stock Option (right-to-buy) Options Exercise $0 -1.22K -100% $0.00 0 Aug 6, 2025 Common Stock 1.22K $141.60 Direct F3
transaction IDXX Non-Qualified Stock Option (right-to-buy) Options Exercise $0 -5.87K -100% $0.00 0 Aug 6, 2025 Common Stock 5.87K $178.26 Direct F4
transaction IDXX Non-Qualified Stock Option (right-to-buy) Options Exercise $0 -5.71K -100% $0.00 0 Aug 6, 2025 Common Stock 5.71K $206.94 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes a total of 28.7090 shares purchased under the Issuer Employee Stock Purchase Plan on March 31, 2025 and June 30, 2025.
F2 Represents the weighted average price of the shares sold ranging from a low of $630.50 to a high of $630.94 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
F3 Grant of option to buy shares of Issuer common stock that became exercisable in five annual installments beginning February 14, 2018.
F4 Grant of option to buy shares of Issuer common stock that became exercisable in five annual installments beginning February 14, 2019.
F5 Grant of option to buy shares of Issuer common stock that became exercisable in five annual installments beginning February 14, 2020.